Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer Meeting Abstract


Authors: Drilon, A.; Moreno, V.; Patel, J.; Lassen, U.; Solomon, B.; Rosen, L.; Leyvraz, S.; Tan, D. S. W.; Reeves, J. A.; Dima, L.; Brega, N.; Kummar, S.; Farago, A. F.
Abstract Title: Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Meeting Title: 2020 North America Conference on Lung Cancer
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 1 Suppl.
Meeting Dates: 2020 Oct 16-17
Meeting Location: Virtual
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-01-01
Start Page: S30
End Page: S31
Language: English
ACCESSION: WOS:000610079600062
PROVIDER: Clarivate Analytics Web of Science
PROVIDER: wos
DOI: 10.1016/j.jtho.2020.10.140
Notes: Meeting Abstract: MO01.35 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon